{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:23Z","timestamp":1787026583534,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s syndrome (SS) is a systemic autoimmune disease that affects about 0.04-0.1% of the general population. SS diagnosis depends on symptoms, clinical signs, autoimmune serology, and even invasive histopathological examination. This study explored biomarkers for SS diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We downloaded three datasets of SS patients\u2019 and healthy pepole\u2019s whole blood (GSE51092, GSE66795, and GSE140161) from the Gene Expression Omnibus (GEO) database. We used machine learning algorithm to mine possible diagnostic biomarkers for SS patients. Additionally, we assessed the biomarkers\u2019 diagnostic value using the receiver operating characteristic (ROC) curve. Moreover, we confirmed the expression of the biomarkers through the reverse transcription quantitative polymerase chain reaction (RT-qPCR) using our own Chinese cohort. Eventually, the proportions of 22 immune cells in SS patients were calculated by CIBERSORT, and connections between the expression of the biomarkers and immune cell ratios were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We obtained 43 DEGs that were mainly involved in immune-related pathways. Next, 11 candidate biomarkers were selected and validated by the validation cohort data set. Besides, the area under curves (AUC) of XAF1, STAT1, IFI27, HES4, TTC21A, and OTOF in the discovery and validation datasets were 0.903 and 0.877, respectively. Subsequently, eight genes, including HES4, IFI27, LY6E, OTOF, STAT1, TTC21A, XAF1, and ZCCHC2, were selected as prospective biomarkers and verified by RT-qPCR. Finally, we revealed the most relevant immune cells with the expression of HES4, IFI27, LY6E, OTOF, TTC21A, XAF1, and ZCCHC2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this paper, we identified seven key biomarkers that have potential value for diagnosing Chinese SS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1023248","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:32:09Z","timestamp":1686616329000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Screening biomarkers for Sjogren\u2019s Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells"],"prefix":"10.3389","volume":"14","author":[{"given":"Yafang","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyou","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donge","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren\u2019s syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102364","article-title":"Sjogren\u2019s syndrome: old and new therapeutic targets","volume":"110","author":"Mavragani","year":"2020","journal-title":"J Autoimmun"},{"key":"B4","article-title":"Evaluation of soluble Cd25 as a clinical and autoimmune biomarker in primary sj\u00f6gren\u2019s syndrome","volume":"126","author":"Chen","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B5","article-title":"Mediterranean Diet and risk of sj\u00f6gren\u2019s syndrome","volume":"126","author":"Machowicz","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000667","article-title":"Primary sjogren syndrome in han Chinese: clinical and immunological characteristics of 483 patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0961203319889666","article-title":"Characteristics of Chinese patients with primary Sjo\u00a8Gren\u2019s:Syndrome_ preliminary report of a multi-centre registration study","volume":"29","author":"Xu","year":"2020","journal-title":"Lupus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.004","article-title":"Incidence, mortality, and causes of death in physician-diagnosed primary sjogren\u2019s syndrome in Korea: a nationwide, population-based study","volume":"47","author":"Kim","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04744-6","article-title":"Survival analysis of patients with sjogren\u2019s syndrome in Turkey: a tertiary hospital-based study","volume":"39","author":"Yazisiz","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary sjogren syndrome: predicting survival using the eular-ss disease activity index (Essdai) in 1045 patients","volume":"75","author":"Brito-Zeron","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211020179","article-title":"Ten-year survival analysis of patients with primary sjogren\u2019s syndrome in China: a national prospective cohort study","volume":"13","author":"Qian","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.40040","article-title":"Genome-wide association analysis reveals genetic heterogeneity of sjogren\u2019s syndrome according to ancestry","volume":"69","author":"Taylor","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2017.78.8.438","article-title":"Sjogren\u2019s syndrome","volume":"78","author":"Thorne","year":"2017","journal-title":"Br J Hosp Med (Lond)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary sj\u00f6gren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2015.06.002","article-title":"Biomarkers for primary sjogren\u2019s syndrome","volume":"13","author":"Chen","year":"2015","journal-title":"Genomics Proteomics Bioinf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2017-0297","article-title":"Biomarkers for sjogren\u2019s syndrome","volume":"12","author":"Baldini","year":"2018","journal-title":"biomark Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary sjogren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket179","article-title":"Characterization of a new regulatory Cd4+ T cell subset in primary sjogren\u2019s syndrome","volume":"52","author":"Alunno","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B20","first-page":"10","article-title":"One year in review 2020 comorbidities, diagnosis and treatment of primary sj\u00f6gren\u2019s syndrome","volume":"126","author":"Manfr\u00e8","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2009.04.004","article-title":"Human Th17 cells in infection and autoimmunity","volume":"11","author":"Sallusto","year":"2009","journal-title":"Microbes Infect"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873787","article-title":"Screening biomarkers for systemic lupus erythematosus based on machine learning and exploring their expression correlations with the ratios of various immune cells","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.21037\/atm-22-1533","article-title":"A cerna regulatory network in systemic lupus erythematosus and its molecular interplay with cancer","volume":"10","author":"Lin","year":"2022","journal-title":"Ann Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2799-4","article-title":"Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus","volume":"34","author":"Feng","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sjogren\u2019s syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40259-021-00505-7","article-title":"Targeted therapy for primary sjogren\u2019s syndrome: where are we now","volume":"35","author":"Wang","year":"2021","journal-title":"BioDrugs"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195113","article-title":"Combined classification system based on Acr\/Eular and ultrasonographic scores for improving the diagnosis of sjogren\u2019s syndrome","volume":"13","author":"Takagi","year":"2018","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105132","article-title":"Elderly-onset primary sjogren\u2019s syndrome focused on clinical and salivary gland ultrasonographic features","volume":"88","author":"Lee","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S322318","article-title":"Bioinformatics analysis for identification of key genes in salivary gland and the potential of a combination of biomarkers for the diagnosis of ss","volume":"14","author":"Chen","year":"2021","journal-title":"J Inflamm Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/ylte6v","article-title":"Untargeted serum metabolomics and potential biomarkers for sj\u00f6gren\u2019s syndrome","volume":"133","author":"Xu","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697157","article-title":"Integrated bioinformatics and validation reveal potential biomarkers associated with progression of primary sjogren\u2019s syndrome","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2021-0296","article-title":"Construction of a lncrna-Mirna-Mrna network to determine the key regulators of the Th1\/Th2 imbalance in multiple sclerosis","volume":"13","author":"Azari","year":"2021","journal-title":"Epigenomics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105125","article-title":"Molecular basis of complement C1q collagen-like region interaction with the immunoglobulin-like receptor lair-1","volume":"22","author":"Fouet","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4067\/S0716-97602011000100007","article-title":"Contribution of dendritic Cell\/T cell interactions to triggering and maintaining autoimmunity","volume":"44","author":"Llanos","year":"2011","journal-title":"Biol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652771","article-title":"Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key332","article-title":"B cells in sj\u00f6gren\u2019s syndrome: from pathophysiology to therapeutic target","volume":"60","author":"Mielle","year":"2021","journal-title":"Rheumatology"},{"key":"B37","article-title":"Blocking T cell Co-stimulation in primary sj\u00f6gren\u2019s syndrome_ rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers","volume":"126","author":"Pontarini","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of b cells in the pathogenesis of sjogren\u2019s syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102439","article-title":"Gene expression profiling of epithelium-associated Fcrl4(+) b cells in primary sjogren\u2019s syndrome reveals a pathogenic signature","volume":"109","author":"Verstappen","year":"2020","journal-title":"J Autoimmun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135982","article-title":"M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary sjogren\u2019s syndrome","volume":"5","author":"Abe","year":"2020","journal-title":"JCI Insight"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210788","article-title":"Multiomic disease signatures converge to cytotoxic Cd8 T cells in primary sjogren\u2019s syndrome","volume":"76","author":"Tasaki","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5MR1020-057RR","article-title":"Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary sjogren\u2019s syndrome","volume":"109","author":"Chen","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in sjogren\u2019s syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100486","article-title":"Activation of the interferon pathway in peripheral blood of patients with sjogren\u2019s syndrome","volume":"38","author":"Kimoto","year":"2011","journal-title":"J Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01142","article-title":"Identifying key genes and functionally enriched pathways in sjogren\u2019s syndrome by weighted gene Co-expression network analysis","volume":"10","author":"Yao","year":"2019","journal-title":"Front Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in Cd14 monocytes of patients with sjogren\u2019s syndrome and association with disease activity and baff gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.226126","article-title":"Hes1 and Hes4 have non-redundant roles downstream of notch during early human T-cell development","volume":"106","author":"De Decker","year":"2021","journal-title":"Haematologica"},{"key":"B49","doi-asserted-by":"publisher","first-page":"106077","DOI":"10.1016\/j.intimp.2019.106077","article-title":"Increased expression of Ttc21a in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level","volume":"78","author":"Wang","year":"2020","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1023248\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:32:16Z","timestamp":1686616336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1023248\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2023.1023248"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1023248","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"article-number":"1023248"}}